Skip to content
Thursday, January 21, 2021
Latest:
  • Are herbal supplements safe?
  • Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves
  • Is the COVID-19 vaccine safe for pregnant women?
  • Black excellence: Pursuing society’s view of exceptionalism at the expense of our humanity
  • Reaching the ‘unreachable’: The final frontier in medicine

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Connect With Us
  • bcm.edu

Chemotherapy

From The Labs 

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019June 25, 2019 Ana Rodríguez 1 Comment Breast Cancer, Chemotherapy, Clinical Trials, HER2 gene, lapatinib, PI3K pathway, Research, trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive

Read more
From The Labs 

Mutant PPM1D gives stem cells a survival advantage

January 8, 2019January 8, 2019 Ana Rodríguez 0 Comments Cancer, Chemotherapy, clonal hematopoiesis, PPM1D, Research, secondary leukemia

Scroll down to watch the video summary of this work. Although chemotherapy can fight back cancer, it also has been associated with increased risk of

Read more
From The Labs 

Searching for targets for ependymoma chemotherapy

March 8, 2018March 8, 2018 Ana Rodríguez 0 Comments Chemotherapy, childhood brain tumor, ependymoma, epigenomisc, Genomics, Research

From a clinical perspective, the treatment for ependymoma – the third most common childhood brain tumor – has changed little over the last 20 years.

Read more
Dr. Sedgwick and Dr. Sepulveda
Momentum 

Improving quality of life, management of breast cancer care

October 21, 2013October 7, 2016 Momentum 0 Comments Breast Cancer, Cancer, Chemotherapy, Clinical research, Dr. Julie Nangia, Dr. Kent Osborne, Glenna Picton

Throughout their journey, breast cancer patients and survivors may face a number of challenges as they steward through diagnosis, treatment and prevention of recurrence. In

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs kicks off the new year with the most viewed Image of the Month of 2020.

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951